RxDoctor Payments Data

Rebekah Heyen

Family · Clinton, INNPI 1912603697

Payments from drug & device makers

$5,021in general payments, 2019–2025

Across 242 payments — averaging $20.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$826
  • Novo Nordisk$649
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$614
  • Takeda Pharmaceuticals U.S.A., Inc.$461
  • Alkermes, Inc.$455
  • Amgen$402
  • plus $2K from 17 others

What the payments were for

  • Food & beverage$4,94699%
  • Education$751%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,021 in reported general payments places this provider in the 90th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide60$83,075
MounjaroTirzepatide43$67,811
JardianceEmpagliflozin22$36,215
RybelsusSemaglutide16$35,633
Tresiba Flextouch U-200Insulin Degludec19$17,833
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$17,800
TrulicityDulaglutide17$16,497
Repatha SyringeEvolocumab14$8,911
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$7,076
Diclofenac Sodium ErDiclofenac Sodium38$2,536
Vilazodone Hcl16$2,137
Testosterone Cypionate26$1,663
Ezetimibe65$1,538
Atorvastatin Calcium104$857
Levothyroxine Sodium75$840

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$649$118,70876 claims
Lilly USA, LLCMounjaro, Trulicity$246$84,30860 claims
Boehringer IngelheimJardiance$147$36,21522 claims
GSKTrelegy Ellipta$94$17,80018 claims
AstraZenecaBreztri Aerosphere$177$7,07611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,392 family providers in Indiana.

Other family in Clinton

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →